Growth forecast for global insulin pump market

Let us see what is an insulin pump? And where it is used? So the answer is Insulin pump is a medical device that is used for the administration of insulin in the treatment of diabetes. Before the introduction of Insulin pumps, patients were treated through incursive insulin needles, tablets or insulin delivered via inhalable pumps.

Global insulin pump market is expected to cross US$ 8 Billion by 2024. The expansion of diabetes management policy and addition of diabetes technology across the world, the market for insulin pump will cultivate positive outlook in an anticipated year. With the help of insulin pump patients manage their diabetes with high degree of efficiency without frequent support from physician. In addition, there are lots of assessments has been done so far associated with insulin pump and it shows quite favorable results.

In the current scenario, patients or the people who suffer from diabetes easily get to know the current position due to the introduction of insulin pump. Insulin Pump is a little automated gadget relatively like a cell phone. It is extremely convenient to use, as this can be effectively fit inside a pocket. The gadget comprises of buttons to program insulin and explore through the menu, LCD shading screen to demonstrate the programming, battery compartment and a store compartment.

A look upon what Players of Insulin Pump doing for the Growth of this Market

As we all know that because of the innovation in Health care and fighting against diabetes, companies played a very prominent role in the expansion of this market. The companies like Medtronic, Insulet Corporation, Tandem Diabetes Care etc. with their research and development in the field of diabetes made a great impact on patients globally.

Medtronic has continuously improved and innovate on core technologies to help people with diabetes, continue to experience greater freedom and better health. The products of Medtronics such as, CareLink Personal Therapy Management Software, CareLink ProTherapy Management Software, Guardian REAL-Time Continuous Glucose Monitoring System, Infusion Sets, Insulin Pumps with Continuous Glucose Monitors, iPro 2 Professional CGM etc.

Apart from that, Medtronic has launched one more product recently MiniMed Mio Advance infusion set.

Insulet Corporation offers tubeless insulin pump technology with its Omnipod Insulin Management System i.e. Omnipod System. Insulet Corporation, in collaboration with NXP semiconductor technology that helps to free patients from conventional medical tubes.

Newly, Insulet Corporation to launch a new data for its Omnipod Horizon Automated Glucose Control System i.e. Omnipod Horizon, hybrid closed-loop system.

Tandem Diabetes Care is a medical device company and also the manufacturer of the only touchscreen insulin pumps. Tandem products say for instance, t:slim X2, t:flex Pump, etc.

The product t:slim X2 is capable of reducing time in hypoglycemia and also enhanced the time range. Apart from that t:flex pump has the capability to hold up to 480 units of insulin, if the patients with larger insulin requirements.

Click here for:

Medical Devices Research Report:

Reimbursement policies in developed nations made a great impact on patients fight against diabetes

If we discuss about the developed nation, the overall scenario of the Diabetes patients is quite different from developing nations. Countries like the United States, Europe, Australia, etc, their governments prior involvement in the Healthcare as well as facilities like reimbursement, insurance policies make the patients fight against the diseases. Although, developing countries has not many facilities as developed nations have in the Healthcare, but at the same time, due to globalizations and government involvements in the field of Healthcare and also the efforts of Multinational companies towards better Healthcare system, developing nations moving towards it.

Contact US Renub Research Phone: +1-678-302-0700 Email: info@renub.com